Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Discover wealth creation techniques that work and can significantly enhance your financial success. Start implementing these strategies today!
11,253 articlesA trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Two rising names—Oklo and Centrus Energy—are shaping the future of U.S. nuclear energy. This guide breaks down which ...
Powell Industries may fly under the radar, but patient investors can uncover a potential opportunity. This guide brea...
RadNet is entering 2026 with a mix of imaging volumes, payer dynamics, and technology investments. This guide breaks ...
KB Home lands its first land deal in the Atlanta area, purchasing 110 homesites for the Whitley Meadows community and...
SpaceX aims for a record public debut valued at $1.75 trillion. History warns mega-IPOs can swing wildly in year one,...
A surge in data-center construction collides with a persistent skilled-trades shortage. Firms are rolling out aggress...
UPS has faced a rough stretch, but signs of a turnaround are catching investor attention. This guide explains why Jul...
When a mining stock pops today, investors sit up. Discover the drivers behind SSR Mining's rally, what it means for r...
A Minneapolis-area father and son are under indictment for allegedly filing false tax refunds using a questionable se...
Meta Platforms rolls out a new AI compute offering for external customers, aiming to outpace cloud giants. The move t...
Thinking you can simply buy the Dow and call it a day? This article explains why a low-cost ETF that tracks the Dow—o...